293 related articles for article (PubMed ID: 28263795)
1. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
2. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
3. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
4. Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods.
Iwata M; Nakamura Y; McGinity JW
J Microencapsul; 1999; 16(1):49-58. PubMed ID: 9972502
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
Zhu KJ; Jiang HL; Du XY; Wang J; Xu WX; Liu SF
J Microencapsul; 2001; 18(2):247-60. PubMed ID: 11253941
[TBL] [Abstract][Full Text] [Related]
6. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
Iwata M; McGinity JW
J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
[TBL] [Abstract][Full Text] [Related]
7. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
8. Influence of shaking and surfactants on the release of bsa from plga microspheres.
Hernádez RM; Igartua M; Gascón AR; Calvo MB; Pedraz JL
Eur J Drug Metab Pharmacokinet; 1998; 23(2):92-6. PubMed ID: 9725463
[TBL] [Abstract][Full Text] [Related]
9. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
Liang D; Frank S; Schwendeman SP
Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895
[TBL] [Abstract][Full Text] [Related]
10. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
13. Development of biodegradable drug delivery system to treat addiction.
Mandal TK
Drug Dev Ind Pharm; 1999 Jun; 25(6):773-9. PubMed ID: 10349563
[TBL] [Abstract][Full Text] [Related]
14. Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations.
Zhang Y; Zhang R; Illangakoon UE; Harker AH; Thrasivoulou C; Parhizkar M; Edirisinghe M; Luo CJ
Int J Nanomedicine; 2020; 15():5389-5403. PubMed ID: 32801695
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
[TBL] [Abstract][Full Text] [Related]
16. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
Uchida T; Goto S; Foster TP
J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
[TBL] [Abstract][Full Text] [Related]
17. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
Shah RB; Schwendeman SP
J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
[TBL] [Abstract][Full Text] [Related]
18. Quality-by-Design Based Development of Doxycycline Hyclate-Loaded Polymeric Microspheres for Prolonged Drug Release.
Longre S; Rana D; Rangra S; Jindal AB; Salave S; Vitore J; Benival D
AAPS PharmSciTech; 2024 Feb; 25(3):49. PubMed ID: 38424393
[TBL] [Abstract][Full Text] [Related]
19. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
Takada S; Kurokawa T; Miyazaki K; Iwasa S; Ogawa Y
Pharm Res; 1997 Sep; 14(9):1146-50. PubMed ID: 9327440
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
